Uipath Inc (PATH)
Official siteTECHNOLOGY • SOFTWARE - INFRASTRUCTURE • NYSE
Market Cap: $6.92B
Last updated: Nov 17, 2026 at 11:06 AM ET
Uipath Inc (PATH) P/E Ratio & Valuation History
Uipath (PATH) trades at 21.5x trailing earnings and 4.0x sales. Its P/E of 21.5x is below its 5-year median of 31.5x. Its forward P/E is 14.5x. The median P/E across 8 similar companies is 39.7x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 48.3% higher over the next year. Its free cash flow yield is 5.3%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 21.5x |
| Forward P/E | 14.5x |
| Price to sales | 4.0x |
| Price to book | 3.5x |
| EV/EBITDA | 20.9x |
| Price to FCF | 18.8x |
| EV/FCF | 17.1x |
| PEG | 0.4 |
| FCF yield | 5.3% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 21.5x | 31.5x | N/A |
| P/S | 4.0x | 6.1x | N/A |
| P/B | 3.5x | 4.3x | N/A |
Valuation History
Over the 4 of the 5 year ends shown that have a P/E, its P/E ranged from 25.4x in 2024 to 254.2x in 2022.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $16.39 | 31.5x | 5.7x | 4.5x |
| 2024 | $12.71 | 25.4x | 5.1x | 4.0x |
| 2023 | $24.84 | 52.9x | 11.5x | 7.2x |
| 2022 | $12.71 | 254.2x | 6.6x | 3.8x |
| 2021 | $43.13 | N/A | 21.0x | 12.2x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PATH
What is PATH's forward P/E ratio?
Uipath has a forward P/E ratio of 14.5x.
Is PATH stock overvalued?
GNG's valuation label for PATH is Undervalued. Its P/E of 21.5x compares with a median of 39.7x across 8 similar companies.
What is PATH's price to sales ratio?
Uipath has a price to sales ratio of 4.0x.
What is Uipath's average P/E ratio over 5 years?
Uipath's median P/E over the last 5 years is 31.5x, from 49 month-end values through Oct 2026.
What is PATH's PEG ratio?
Uipath has a PEG ratio of 0.4.
PATH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors